treatment for the 3rd quarter of Year 2018 and 2019 were in amounts of Baht 154.39 million and Baht 207.0 million, respectively, which increased by Baht 50.61 million or in the proportion of 34.1%. These
. These entries were recorded in the accounting books and financial statements for the fiscal year 2023, as well as in the accounting documents for the first quarter of 2024 and other related reports of JKN
and subsidiary have profit for the first quarter 2020 of 62.1 Million Baht increased 1.8 Million Baht compared with last year (the first quarter 2019, there were profit for the year 60.3 Million Baht
and subsidiary have profit for the second quarter 2020 of 35.2 Million Baht increased 8.5 Million Baht compared with last year (the second quarter 2019, there were profit for the year 26.7 Million Baht
, representing overall decrease of loss equivalent to 103.73%. The result comes from the main factors as follows: 1. Other Incomes were Baht 3.21 Million decreased from the same period of year 2016 for Baht 8.18
441.89 million increased from the same period of year 2016 by Baht 59.68 million or 15.61 percent. The major reasons of the increase in revenues from sales were due to the effective sales and marketing
for the 2ndquarter of Year 2017 and 2018 were in amounts of Baht 126.83 million and Baht 135.14 million, respectively, which increased by 6.5% compared to the total revenue. The revenue from In-patients
fees The Company’s brokerage fees in 2Q2018 were Baht 223 million, an increase of 15% from 2Q2017, mainly due to an increase in the SET average daily trading volume. 1.2 Fees and Service income The
to the third quarter of the previous year. The significant revenue items are as follows: 1.1 Brokerage fees The Company’s brokerage fees in the third quarter of 2019 were Baht 212 million, similar to